- Pressemitteilung BoxID 481240
European tool enables companies to open up markets
Transnational BIOMAT-In cooperation project launched
Biomaterials are already used in a large number of medical areas. Contact lenses, dentures, heart valves and artificial hip joints are all items that form an interface between synthetically produced materials and the human biological system. The potential for innovations in this field of research is immense, with a constant influx of new findings from sectors such as material sciences, electronics and nanotechnology.
From an interdisciplinary research perspective, developing a transnational network of all players in the biomaterials sector, i.e. industry, research, hospitals and companies, is vital. Together with four other European leading-edge clusters from France, the Netherlands and the UK, the STERN BioRegion will in future be promoting innovations in this area as part of the BIOMAT-In project. Unique expertise in regenerative medicine and tissue engineering is already concentrated in the STERN BioRegion. Numerous research institutes, hospitals and companies work here intensively on medical applications in areas such as skin and wound treatment and cardiovascular disease.
These findings and data from the cooperating clusters will be pooled into a database over the next three years, giving entrepreneurs an overview of the entire European network together with key information on the relevant approval procedures and market opportunities. The project will be accompanied by a range of events and network activities. For instance, matchmaking events will bring together research institutes and companies from the various regions for development and production projects and a voucher system will also provide incentives for transnational cooperation. The project has a budget totalling EUR 1.24 million, of which EUR 223,000 is available to BioRegio STERN Management GmbH.
European cooperation projects such as BIOMAT-In are necessary and useful, says project manager Dr. Manfred Kauer. "Healthcare markets are national and highly regulated. Companies looking to operate across national borders still have to collate the approval procedures and market opportunities in the respective countries. BIOMAT-In will provide all the key information at the touch of a button, enabling our export-oriented companies to open up international markets."
For further information on the BIOMAT-In project, go to www.biomatin.eu
The EU BIOMAT-In project encourages new business relationships between small and medium-sized enterprises and research institutes in biomaterials and tissue engineering. The project is supported by five leading European clusters - Eurasanté and Atlanpole Biotherapies in France, the STERN Bioregion in Germany, LIOF in the Netherlands and Medilink East Midlands in the UK.
Launched in March 2011, the project will run for three years and has a budget of EUR 1.24 million. It is part funded by the European Regional Development Fund (ERDF) as part of the Interreg IVB North-West Europe programme.
Über BioRegio STERN Management GmbH
For ten years, BioRegio STERN Management GmbH has been a skill-sharing network in the cities of Stuttgart, Tübingen, Esslingen, and Reutlingen and the Neckar-Alb and Stuttgart regions in the Baden-Württemberg area of Germany, providing a source of help and advice for founders of new businesses, entrepreneurs and researchers from the biotechnology sector. BioRegio STERN Management GmbH represents their interests in dealings with politicians, the media and associations. It offers business promotion and marketing services and provides advice on grant applications and corporate financing. Regenerative medicine, medical technology and the automation of biotechnology are key focal points. The Managing Director, Dr. Klaus Eichenberg, is a molecular and cell biologist and investment analyst.
Diese Pressemitteilungen könnten Sie auch interessieren
Fachtagung 2013 des Gissel Instituts: Aktuelle Themen rund um die Fleischverarbeitung stehen im Blickpunkt
Kaum eine Veranstaltung dürfte geeigneter sein, sich in Sachen Fleisch und Fleischwaren auf den neuesten Stand zu bringen, als die regelmäßige Fachtagung des renommierten...
BioTek kündigt stolz die erste Kombination aus Multi-Detektions-Reader mit Hybrid-Technologie und Imaging-System an - den Cytation™3 Multi-Detektions-Reader für...
In a newly created award, pRED's Discovery Oncology unit of Roche (SIX: RO, ROG; OTCQX: RHHBY) in Penzberg, Germany invites European researchers to submit abstracts...